Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dystrophin connection--ATP?

C A Bonsett1, A Rudman

  • 1Department of Neurology, Indiana University School of Medicine, Indianapolis 46223.

Medical Hypotheses
|June 1, 1992
PubMed
Summary

This study suggests muscular dystrophies involve ATP pathway abnormalities. Adenylosuccinic acid (ASA) showed potential in correcting creatine and calcium metabolism issues in patients with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical diagnostic systems: a case for neural networks.

Technology and health care : official journal of the European Society for Engineering and Medicine·2014
Same author

Balantidium coli-induced pulmonary haemorrhage with iron deficiency.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2010
Same author

The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program.

Clinical pharmacology and therapeutics·2007
Same author

Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.

The pharmacogenomics journal·2006
Same author

The need for education in pharmacogenomics: a regulatory perspective.

The pharmacogenomics journal·2005
Same author

'Oil globules' in Duchenne muscular dystrophy--history, demonstration, and metabolic significance.

Medical hypotheses·1994

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neurology

Background:

  • Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are dystrophin-defective muscle diseases.
  • These conditions are hypothesized to involve metabolic abnormalities within the adenosine triphosphate (ATP) pathway.
  • Understanding these metabolic disruptions is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of the ATP pathway in the metabolic abnormalities of DMD and BMD.
  • To evaluate the therapeutic potential of synthetically produced adenylosuccinic acid (ASA).
  • To analyze clinical features for disease-accelerating mechanisms.

Main Methods:

  • Clinical evidence was gathered and analyzed.
  • Laboratory parameters related to creatine and calcium metabolism were assessed.
  • The effects of glucagon-stimulated cyclic adenosine monophosphate (c-AMP) and ASA were examined.

Main Results:

  • Objective laboratory data indicated corrective trends in abnormal creatine and calcium metabolism parameters.
  • These trends were observed following interventions using glucagon-stimulated c-AMP and ASA.
  • Clinical features provided insights into potential disease-accelerating mechanisms.

Conclusions:

  • The findings support the hypothesis that ATP pathway dysfunction is central to DMD and BMD metabolic abnormalities.
  • Adenylosuccinic acid (ASA) demonstrates therapeutic potential for correcting metabolic imbalances in muscular dystrophies.
  • Further research into ASA and disease mechanisms is warranted.

Related Experiment Videos